Labshake search
Citations for R&D Systems :
451 - 500 of 2563 citations for Recombinant Human S100 Calcium Binding Protein A9 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2023Quote: ... Stock recombinant zebrafish BMP4 protein (R&D Systems 1128-BM-010) was reconstituted to 20 µg/mL in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Microbiology 2023Quote: ... 200ng of recombinant ANXA2 protein (Cat# 9409-AN, R&D Systems) diluted in PBS ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant mouse IL-15Ralpha Fc chimera protein (R&D Systems), in RPMI medium (Corning Life Sciences ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Pathology 2023Quote: The ROSAKIT WT human cell line (RRID:CVCL_5G49) was cultured in the presence of recombinant human SCF (80 ng/mL, R&D Systems), as described previously (23) ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Neuroscience 2019Quote: Recombinant human IDO (Accession #P14902) was obtained from R&D Systems (#6030-AO-010) and frozen at −80°C until use ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant human TGFβ-1 (cat# 240B002) was purchased from R&D systems (Minneapolis, MN). Alexa 488-conjugated phalloidin (cat# A12379 ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...
-
bioRxiv - Microbiology 2019Quote: ... An isotype control (Recombinant Human IgG1 Fc, CF; R&D Systems; 110-HG-100) and recombinant rotavirus NSP4 protein were used as controls respectively ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Immunology 2022Quote: ... supplemented with 30 U/mL recombinant human IL-2 (R&D Systems #202-IL), and 55 μM beta- mercaptoethanol (Thermo # 21985023) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Physiology 2020Quote: ... at concentrations between 1-100 nM or recombinant human sclerostin (rhSCL) (R&D Systems) at concentrations between 1-50 ng/ml [28 ...
-
bioRxiv - Immunology 2019Quote: ... overnight before addition of 500 IU/ml recombinant human IL-2 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... the samples were treated with human recombinant LOXL3 (RhLOXL3, R&D systems, 6069-AO) or LOXL2 (RhLOXL2 ...
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...